1-11 of 11
Guillaume Charpentier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Association Between the ACE Insertion/Deletion Polymorphism and Risk of Lower-Limb Amputation in Patients With Long-Standing Type 1 Diabetes

Kamel Mohammedi, Yawa Abouleka, Charlyne Carpentier, Louis Potier, Severine Dubois, Ninon Foussard, Vincent Rigalleau, Jean-François Gautier, Pierre Gourdy, Guillaume Charpentier, Ronan Roussel, André Scheen, Bernard Bauduceau, Samy Hadjadj, François Alhenc-Gelas, Michel Marre, Gilberto Velho
Journal: Diabetes Care
Diabetes Care 2022;45(2):407–415
DOI: https://doi.org/10.2337/dc21-0973
Published: 01 December 2021
View article titled, Association Between the ACE Insertion/Deletion Polymorphism and Risk of Lower-Limb Amputation in Patients With Long-Standing Type 1 Diabetes
Click here to open pdf in another window PDF for Association Between the ACE Insertion/Deletion Polymorphism and Risk of Lower-Limb Amputation in Patients With Long-Standing Type 1 Diabetes
Journal Articles

Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-Month Follow-up

Coralie Amadou, Sylvia Franc, Pierre-Yves Benhamou, Sandrine Lablanche, Erik Huneker, Guillaume Charpentier, Alfred Penfornis
Journal: Diabetes Care
Diabetes Care 2021;44(3):844–846
DOI: https://doi.org/10.2337/dc20-1809
Published: 11 January 2021
View article titled, Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-Month Follow-up
Click here to open pdf in another window PDF for Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-Month Follow-up
Journal Articles

Comment on Leelarathna et al. Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes. Diabetes Care 2020;43:e38–e39

Pierre Yves Benhamou, Stéphanie Madrolle, Sandrine Lablanche, Alexandre Gallegos, Yousra Tourki, Sylvia Franc, Maeva Doron, Guillaume Charpentier
Journal: Diabetes Care
Diabetes Care 2020;43(10):e167
DOI: https://doi.org/10.2337/dc20-1291
Published: 11 September 2020
View article titled, Comment on Leelarathna et al. Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes. Diabetes Care 2020;43:e38–e39
Click here to open pdf in another window PDF for Comment on Leelarathna et al. Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes. Diabetes Care 2020;43:e38–e39
Journal Articles

Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial

Andrew J. Ahmann, Matthew Capehorn, Guillaume Charpentier, Francesco Dotta, Elena Henkel, Ildiko Lingvay, Anders G. Holst, Miriam P. Annett, Vanita R. Aroda
Journal: Diabetes Care
Diabetes Care 2018;41(2):258–266
DOI: https://doi.org/10.2337/dc17-0417
Published: 15 December 2017
View article titled, Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial
Click here to open pdf in another window PDF for Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial
Includes: Supplementary data
Journal Articles

Quality of Care of People With Type 2 Diabetes in Eight European Countries: Findings from the Guideline Adherence to Enhance Care (GUIDANCE) study

Margaret A. Stone, PHD, Guillaume Charpentier, MD, Kris Doggen, PHD, Oliver Kuss, PHD, Ulf Lindblad, MD, PHD, Christiane Kellner, MD, John Nolan, MD, Agnieszka Pazderska, MD, Guy Rutten, MD, PHD, Marina Trento, MEDSCI, BPSYCHOL, MBA, Kamlesh Khunti, MD, PHD, On behalf of the GUIDANCE Study Group
Journal: Diabetes Care
Diabetes Care 2013;36(9):2628–2638
DOI: https://doi.org/10.2337/dc12-1759
Published: 13 August 2013
View article titled, Quality of Care of People With Type 2 Diabetes in Eight European Countries: <span class="subtitle">Findings from the Guideline Adherence to Enhance Care (GUIDANCE) study</span>
Click here to open pdf in another window PDF for Quality of Care of People With Type 2 Diabetes in Eight European Countries: <span class="subtitle">Findings from the Guideline Adherence to Enhance Care (GUIDANCE) study</span>
Includes: Supplementary data
Journal Articles

Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens: A 1-year multicenter study

Jean-Pierre Riveline, MD, Pauline Schaepelynck, MD, Lucy Chaillous, MD, Eric Renard, MD, Agnès Sola-Gazagnes, MD, Alfred Penfornis, MD, Nadia Tubiana-Rufi, MD, Véronique Sulmont, MD, Bogdan Catargi, MD, Céline Lukas, MD, Régis P. Radermecker, MD, Charles Thivolet, MD, François Moreau, MD, Pierre-Yves Benhamou, MD, Bruno Guerci, MD, Anne-Marie Leguerrier, MD, Luc Millot, MD, Claude Sachon, MD, Guillaume Charpentier, MD, Hélène Hanaire, MD, for the EVADIAC Sensor Study Group
Journal: Diabetes Care
Diabetes Care 2012;35(5):965–971
DOI: https://doi.org/10.2337/dc11-2021
Published: 11 April 2012
View article titled, Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens: <span class="subtitle">A 1-year multicenter study</span>
Click here to open pdf in another window PDF for Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens: <span class="subtitle">A 1-year multicenter study</span>
Includes: Supplementary data
Journal Articles

Clinical and Metabolic Features of Adult-Onset Diabetes Caused by ABCC8 Mutations

Jean-Pierre Riveline, MD, Elise Rousseau, MD, Yves Reznik, MD, Sabrina Fetita, MD, Julien Philippe, MSC, Aurélie Dechaume, MSC, Agnès Hartemann, MD, Michel Polak, MD, Catherine Petit, MD, Guillaume Charpentier, MD, Jean-François Gautier, MD, Philippe Froguel, MD, Martine Vaxillaire, DPHARM
Journal: Diabetes Care
Diabetes Care 2012;35(2):248–251
DOI: https://doi.org/10.2337/dc11-1469
Published: 16 January 2012
View article titled, Clinical and Metabolic Features of Adult-Onset Diabetes Caused by ABCC8 Mutations
Click here to open pdf in another window PDF for Clinical and Metabolic Features of Adult-Onset Diabetes Caused by ABCC8 Mutations
Includes: Supplementary data
Journal Articles

The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA1c in Poorly Controlled Type 1 Diabetic Patients: A 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study)

Guillaume Charpentier, MD, Pierre-Yves Benhamou, MD, Dured Dardari, MD, Annie Clergeot, MD, Sylvia Franc, MD, Pauline Schaepelynck-Belicar, MD, Bogdan Catargi, MD, Vincent Melki, MD, Lucy Chaillous, MD, Anne Farret, MD, Jean-Luc Bosson, MD, Alfred Penfornis, MD, on behalf of the TeleDiab Study Group
Journal: Diabetes Care
Diabetes Care 2011;34(3):533–539
DOI: https://doi.org/10.2337/dc10-1259
Published: 17 February 2011
View article titled, The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA<sub>1c</sub> in Poorly Controlled Type 1 Diabetic Patients: <span class="subtitle">A 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study)</span>
Click here to open pdf in another window PDF for The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA<sub>1c</sub> in Poorly Controlled Type 1 Diabetic Patients: <span class="subtitle">A 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study)</span>
Includes: Supplementary data
Journal Articles

Can Postprandial Blood Glucose Excursion Be Predicted in Type 2 Diabetes?

Sylvia Franc, MD, Dured Dardari, MD, Caroline Peschard, MSC, Jean-Pierre Riveline, MD, Magdalena Biedzinski, MD, Beatrix Boucherie, MD, Catherine Petit, MD, Elisabeth Requeda, MD, Frederic Mistretta, MSC, Michel Varroud-Vial, MD, Guillaume Charpentier, MD
Journal: Diabetes Care
Diabetes Care 2010;33(9):1913–1918
DOI: https://doi.org/10.2337/dc10-0115
Published: 14 June 2010
View article titled, Can Postprandial Blood Glucose Excursion Be Predicted in Type 2 Diabetes?
Click here to open pdf in another window PDF for Can Postprandial Blood Glucose Excursion Be Predicted in Type 2 Diabetes?
Journal Articles

Extreme Subcutaneous Insulin Resistance Successfully Treated by an Implantable Pump

Jean-Pierre Riveline, MD, Jacqueline Capeau, MD, PHD, Jean-Jacques Robert, MD, PHD, Michel Varroud-Vial, MD, Isabelle Cerf-Baron, MD, Anne Deburge, MD, Guillaume Charpentier, MD
Journal: Diabetes Care
Diabetes Care 2001;24(12):2155–2156
DOI: https://doi.org/10.2337/diacare.24.12.2155
Published: 01 December 2001
View article titled, Extreme Subcutaneous Insulin Resistance Successfully Treated by an Implantable Pump
Click here to open pdf in another window PDF for Extreme Subcutaneous Insulin Resistance Successfully Treated by an Implantable Pump
Journal Articles

Diabetes Complications in NIDDM Kindreds Linked to the MODY3 Locus on Chromosome 12q

Gilberto Velho, MD, PHD, Martine Vaxillaire, PHARMD, PHD, Valérie Boccio, Guillaume Charpentier, MD, Philippe Froguel, MD, PHD
Journal: Diabetes Care
Diabetes Care 1996;19(9):915–919
DOI: https://doi.org/10.2337/diacare.19.9.915
Published: 01 September 1996
View article titled, Diabetes Complications in NIDDM Kindreds Linked to the MODY3 Locus on Chromosome 12q
Click here to open pdf in another window PDF for Diabetes Complications in NIDDM Kindreds Linked to the MODY3 Locus on Chromosome 12q